Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
Article Abstract:
The drugs metformin and troglitazone appear to be effective in lowering blood sugar levels in patients with non-insulin-dependent, or type 2, diabetes. Twenty-nine patients with type 2 diabetes were randomly assigned to take either drug for three months and then both drugs for another three months. Individually, both drugs lowered blood sugar levels by 20% to 25%. In combination, they lowered blood sugar another 18% to 21%. Metformin appears to work primarily by inhibiting blood sugar production, while troglitazone increases the rate of sugar metabolism.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
Article Abstract:
The drug troglitazone appears to be effective in lowering blood sugar levels in people with type 2, or adult-onset, diabetes. Researchers randomly assigned 93 people with type 2 diabetes to take various dosages of troglitazone or a placebo. The drug lowered blood sugar levels by about 20% at dosages of 400 or 600 milligrams per day. Most dosages also lowered blood insulin levels. The drug appeared to work by increasing the metabolism of blood sugar up to 45%.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Article Abstract:
Rosiglitazone, metformin, and glyburide were evaluated as initial treatment for type 2 diabetes diagnosed in a double blind, randomized, controlled clinical trial involving 4360 patients. The potential risks and benefits, the profile of adverse events and the costs of these three drugs should all be considered to help inform the choice of pharmacotherapy for patients with type 2 diabetes.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. Decreases in ovarian cytochrome P450c17alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
- Abstracts: The efficacy of external cephalic version and its impact on the breech experience. Effect of external cephalic version at term on fetal circulation
- Abstracts: Management of venous thromboembolism. Efects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep vein thrombosis
- Abstracts: The day Arnold bowed in prayer. Written in the stars. Arnold & Franco
- Abstracts: A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure